tiprankstipranks
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
US Market
BBIO
BridgeBio Pharma
RESEARCH TOOLSreports
Want to see BBIO full AI Analyst Report?

BridgeBio Pharma (BBIO) Income Statement

1,472 Followers

BridgeBio Pharma Income Statement

Last quarter (Q4 2025), BridgeBio Pharma's total revenue was $154.18M, an increase of 2521.22% from the same quarter last year. In Q4, BridgeBio Pharma's net income was $-197.24M. See BridgeBio Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 502.08M$ 221.90M$ 9.30M$ 77.65M$ 69.72M
Gross Profit
$ 473.81M$ 218.02M$ 6.86M$ 74.21M$ 66.60M
Operating Expenses
$ 1.04B$ 811.00M$ 614.23M$ 586.42M$ 643.23M
Depreciation and Amortization
$ 9.00M$ 6.08M$ 6.49M$ 6.77M$ 5.84M
EBITDA
$ -672.88M$ -436.83M$ -565.47M$ -397.44M$ -533.83M
Operating Income
$ -569.09M$ -592.97M$ -607.37M$ -512.20M$ -576.63M
Other Income/Expenses
$ -165.90M$ 50.78M$ -45.88M$ 27.55M$ -9.82M
Pretax Income
$ -734.99M$ -542.19M$ -653.25M$ -484.65M$ -586.45M
Net Income
$ -729.31M$ -535.76M$ -643.20M$ -481.18M$ -562.54M
Per Share Metrics
Basic EPS
$ -3.79$ -2.88$ -3.95$ -3.35$ -3.90
Diluted EPS
$ -3.79$ -2.88$ -3.95$ -3.35$ -3.90
Weighted Average Shares Outstanding
 197.24M 186.08M 162.79M 147.47M 144.36M
Weighted Average Shares Outstanding (Diluted)
 197.24M 186.08M 162.79M 147.47M 144.36M
Currency in USD

BridgeBio Pharma Earnings and Revenue History